AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $661,000 | +60.8% | 28,634 | -1.6% | 0.01% | +60.0% |
| Q3 2020 | $411,000 | -79.4% | 29,100 | -78.0% | 0.01% | -82.1% |
| Q2 2020 | $1,991,000 | +63.2% | 132,017 | 0.0% | 0.03% | +47.4% |
| Q1 2020 | $1,220,000 | -6.4% | 132,017 | -3.3% | 0.02% | +46.2% |
| Q4 2019 | $1,304,000 | +19.1% | 136,483 | 0.0% | 0.01% | +8.3% |
| Q3 2019 | $1,095,000 | -35.7% | 136,483 | 0.0% | 0.01% | -33.3% |
| Q2 2019 | $1,704,000 | -9.9% | 136,483 | -1.8% | 0.02% | -14.3% |
| Q1 2019 | $1,891,000 | +42.0% | 139,034 | 0.0% | 0.02% | +23.5% |
| Q4 2018 | $1,332,000 | -20.8% | 139,034 | 0.0% | 0.02% | +6.2% |
| Q3 2018 | $1,681,000 | -22.6% | 139,034 | 0.0% | 0.02% | -23.8% |
| Q2 2018 | $2,172,000 | +2.5% | 139,034 | -1.4% | 0.02% | -4.5% |
| Q1 2018 | $2,120,000 | -7.3% | 140,971 | -11.3% | 0.02% | 0.0% |
| Q4 2017 | $2,288,000 | +0.1% | 159,008 | +4.9% | 0.02% | +15.8% |
| Q3 2017 | $2,285,000 | +23.8% | 151,525 | -17.3% | 0.02% | +18.8% |
| Q2 2017 | $1,846,000 | +41.2% | 183,324 | 0.0% | 0.02% | +45.5% |
| Q1 2017 | $1,307,000 | +43.5% | 183,324 | 0.0% | 0.01% | +57.1% |
| Q4 2016 | $911,000 | -32.9% | 183,324 | 0.0% | 0.01% | -36.4% |
| Q3 2016 | $1,357,000 | +35.6% | 183,324 | 0.0% | 0.01% | +22.2% |
| Q2 2016 | $1,001,000 | -35.4% | 183,324 | 0.0% | 0.01% | -40.0% |
| Q1 2016 | $1,549,000 | -18.1% | 183,324 | -6.0% | 0.02% | -16.7% |
| Q4 2015 | $1,892,000 | -31.6% | 195,081 | -1.3% | 0.02% | -37.9% |
| Q3 2015 | $2,765,000 | -1.1% | 197,608 | 0.0% | 0.03% | -14.7% |
| Q2 2015 | $2,796,000 | +30.0% | 197,608 | 0.0% | 0.03% | +41.7% |
| Q1 2015 | $2,150,000 | +30.7% | 197,608 | 0.0% | 0.02% | +26.3% |
| Q4 2014 | $1,645,000 | – | 197,608 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |